iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.690
+0.090 (5.62%)
At close: Jun 18, 2026, 4:00 PM EDT
1.660
-0.030 (-1.78%)
After-hours: Jun 18, 2026, 7:56 PM EDT
iBio, Inc. Market Cap
iBio, Inc. has a market cap or net worth of $61.08 million as of June 18, 2026. Its market cap has increased by 274.14% in one year.
Market Cap
61.08M
Enterprise Value
-11.39M
1-Year Change
274.14%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since August 19, 2008, iBio, Inc.'s market cap has increased from $14.01M to $61.08M, an increase of 335.92%. That is a compound annual growth rate of 8.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 61.08M | 40.74% |
| Dec 31, 2025 | 43.40M | 93.61% |
| Dec 31, 2024 | 22.42M | 716.05% |
| Dec 29, 2023 | 2.75M | -41.32% |
| Dec 30, 2022 | 4.68M | -96.09% |
| Dec 31, 2021 | 119.66M | -46.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 66.20M |
| Edesa Biotech | 65.31M |
| MediciNova | 64.97M |
| Seres Therapeutics | 64.01M |
| MiNK Therapeutics | 60.48M |
| PMV Pharmaceuticals | 60.26M |
| TScan Therapeutics | 60.12M |
| Entera Bio | 59.56M |